BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
Vanessa WongMargaret LeeRachel WongJeanne TieJeremy ShapiroJayesh DesaiLouise NottSimone SteelMatthew BurgeBrigette MaAdnan KhattakWei HongPeter GibbsPublished in: Targeted oncology (2021)
LS BRAFmt cancers share many features with RS BRAFmt cancers, including poor survival outcomes. Mature data on the activity of BRAF-targeted therapies in the first-line setting are eagerly awaited.